🔗 Visit the ClinicalTrials.gov page for NCT01327612
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | TRAIL on trial: preclinical advances in cancer therapy. | Trends Mol Med | 2013 | 1.49 |
| 2 | Trial Watch: Immunostimulatory cytokines. | Oncoimmunology | 2012 | 1.19 |
| 3 | Molecular pathways and therapeutic targets in lung cancer. | Oncotarget | 2014 | 1.16 |
| 4 | Targeting cell death signaling in colorectal cancer: current strategies and future perspectives. | World J Gastroenterol | 2014 | 0.87 |
| 5 | Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitors. | Biomed Res Int | 2013 | 0.84 |
| 6 | Principles of antibody-mediated TNF receptor activation. | Cell Death Differ | 2015 | 0.84 |
| 7 | The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. | Biosci Rep | 2014 | 0.83 |
| 8 | A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase. | Cancers (Basel) | 2012 | 0.76 |